z-logo
open-access-imgOpen Access
Amphotericin B-deoxycholate overdose due to administration error in pediatric patients
Author(s) -
Susanne Groeneveld,
Paul E. Verweij,
Louis Van't Hek,
Jos P.M. Bökkerink,
Adilia Warris
Publication year - 2008
Publication title -
medical mycology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.004
H-Index - 86
eISSN - 1460-2709
pISSN - 1369-3786
DOI - 10.1080/13693780701658280
Subject(s) - amphotericin b , amphotericin b deoxycholate , confusion , medicine , antifungal , toxicity , administration (probate law) , intensive care medicine , pharmacology , psychology , dermatology , law , psychoanalysis , political science , caspofungin
Due to the similarity of their generic names, the use of amphotericin B-deoxycholate and liposomal amphotericin B could cause confusion in daily practice. We report two cases of amphotericin B-deoxycholate overdose in infants due to administration errors which raises the issue that the use of this antifungal agent should be questioned because of its severe side effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom